Zivo Bioscience, Inc. (ZIVO) stock
ZIVOOTCBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$6.80+0.30 (+4.62%)
Close on Oct 19, 2026Market cap $25.96MP/E –Yield –
Zivo Bioscience total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
Zivo Bioscience's total debt was $11.66K at Sep 30, 2025. For fiscal 2024 it was $116.20K. The highest annual figure on record is $121.70K in fiscal 2020.
Annual total debt
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $116.20K | – |
| FY2023 | Dec 31, 2023 | $0 | -100.0% |
| FY2022 | Dec 31, 2022 | $105.92K | – |
| FY2021 | Dec 31, 2021 | $0 | -100.0% |
| FY2020 | Dec 31, 2020 | $121.70K | – |
| FY2019 | Dec 31, 2019 | $0 | – |
| FY2012 | Dec 31, 2012 | $0 | -100.0% |
| FY2011 | Dec 31, 2011 | $7.68K | +118.5% |
| FY2010 | Dec 31, 2010 | $3.52K | – |
Quarterly total debt
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2025 | Sep 30, 2025 | $11.66K | -47.1% |
| Q1 FY2025 | Mar 31, 2025 | $254.45K | +399.7% |
| Q4 FY2024 | Dec 31, 2024 | $116.20K | +9.7% |
| Q4 FY2023 | Dec 31, 2023 | $0 | -100.0% |
| Q3 FY2023 | Sep 30, 2023 | $22.03K | -93.0% |
| Q2 FY2023 | Jun 30, 2023 | $50.92K | – |
| Q4 FY2022 | Dec 31, 2022 | $105.92K | -13.0% |
| Q3 FY2022 | Sep 30, 2022 | $263.82K | – |
| Q2 FY2022 | Jun 30, 2022 | $314.01K | – |
| Q4 FY2021 | Dec 31, 2021 | $0 | – |
| Q4 FY2020 | Dec 31, 2020 | $121.70K | – |
| Q4 FY2019 | Dec 31, 2019 | $0 | – |
See a number that looks wrong?